Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0000899243-19-018480

Options or other derivatives

  • Director acquired 27,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
THOMAS FRANK E Director 2019-06-26 Grant or award · Stock Option (Right to Buy) +27,000 27,000 D
Loading xslF345X03/doc4.xml…